Used to treat schizophrenia and controlling nausea, the Glenmark’s prochlorperazine maleate tablets are the generic version of GlaxoSmithKline’s compazine tablets

Glenmark gets USFDA nod to market generic medication

Glenmark Pharmaceuticals said that it has received final approval by the United States Food & Drug Administration (US FDA) for Prochlorperazine Maleate tablets, the generic version of Compazine tablets of GlaxoSmithKline.

Glenmark Pharma gets US FDA nod for generic Prochlorperazine tablets

“Shingrix” launch soon; WPI to mitigate the impact of price cut under NLEM

GSK Pharma Analyst Meet Takeaways - A Mixed Bag: Motilal Oswal

Motilal Oswal recommended Neutral rating on GSK Pharma with a target price of Rs 1340 in its research report dated February 07, 2023.

Neutral GSK Pharma; target of Rs 1340: Motilal Oswal

GlaxoSmithKline Standalone December 2022 Net Sales at Rs 799.11 crore, down 1.1% Y-o-Y

GlaxoSmithKline Consolidated December 2022 Net Sales at Rs 802.30 crore, down 1.67% Y-o-Y

GlaxoSmithKline Pharmaceuticals Ltd on Tuesday reported a 9.45 per cent rise in consolidated net profit at Rs 164.56 crore in the third quarter ended December 31, 2022.

GlaxoSmithKline Pharmaceuticals net profit rises 9.45% to Rs 165 cr in Q3

GlaxoSmithKline Pharmaceuticals Ltd, the Indian unit of UK’s GSK plc, reported a 9.5% rise in profit, in line with analysts’ estimates, as a sharp drop in input costs more than offset revenue decline

GSK’s India unit Q3 profit up 9% as input costs slump, op revenue fell 1.7%

Bharti Airtel, Adani Green Energy, Adani Ports & Special Economic Zone, Ambuja Cements, Hero MotoCorp, Astral, NHPC Ltd. Gujarat Fluorochemicals Ltd. Deepak Nitrite Ltd. Phoenix Mills Ltd. Aditya Birla Fashion and Retail Ltd. Motherson Sumi Wiring India Ltd. GlaxoSmithKline Pharmaceuticals, Navin Fl…

Q3 results to track this week: Airtel, LIC, Tata Steel, Zomato, M&M and more

The land parcel is located on Thanes Pokhran Road II next to GlaxoSmithKline Pharmaceuticals 60-acre land parcel that Oberoi Realty acquired in 2019 for Rs 890 crore. In May, the developer also entered into an agreement to jointly develop an over 4 million sq ft residential project on an 18.3-acre l…

Oberoi Realty acquires Blue Star’s 9-acre land parcel in Thane’s Pokhran Road

These are among the five cases where the CCPA has imposed penalties on entities for issuing misleading advertisements with false claims and adopting unfair means to misguide consumers. Apart from this, the authority has till date issued 85 notices against misleading advertisements and unfair trade p…

Rs 10 lakh penalty imposed on GlaxoSmithKline for misleading ad, parliamentary panel told

Hasn't faired well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Financials growth has been moderate for a few years

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

GlaxoSmithKline Pharmaceuticals is a pharmaceutical company engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company develops a range of products in pharmaceuticals, vaccines and consumer healthcare.